Course Outline
Click on the links below to preview selected pages from this course.
- Introduction
- Definition of Thrombocytopenia
- Signs Associated With Thrombocytopenia
- Which of the following is a clinical sign that is associated with thrombocytopenia?
- Conditions causing increased destruction and consumption of platelets
- Increased Platelet Destruction
- Idiopathic Thrombocytopenic Purpura
- Drug-Induced Thrombocytopenia
- Drug-Induced Thrombocytopenia
- Pathophysiology of Heparin-Induced Thrombocytopenia (HIT)
- Additional Complications Related to Heparin-Induced Thrombocytopenia
- True or False: When heparin-induced thrombocytopenia occurs, the platelet count noticeably decreases IMMEDIATELY after heparin treatment begins.
- Thrombotic Thrombocytopenic Purpura and Hemolytic Uremic Syndrome
- Thrombotic Thrombocytopenic Purpura (TTP) and Hemolytic Uremic Syndrome (HUS)
- Laboratory Findings
- Treatment of TTP
- Which of the following bacteria is often linked to diarrhea-associated hemolytic uremic syndrome?
- Disseminated Intravascular Coagulation
- Conditions causing decreased platelet production
- Diseases and Disorders That Affect the Bone Marrow and Decrease Platelet Production
- True or False: Patients undergoing chemotherapy treatments will have deficiencies in platelet numbers as well as red and white blood cells.
- Other causes of thrombocytopenia
- Variables that cause a false thrombocytopenia
- References
Additional Information
Level of instruction: Intermediate
Intended Audience: Medical laboratory scientists, medical laboratory technicians, pathology residents, MLS students, and other health care personnel who have an interest in this subject matter.
Author information: Betty Ciesla, MS, MLS(ASCP)SH is a faculty member at Morgan State University in Maryland. She holds an MS degree in Biomedical Communication. She has presented at national workshops in Hematology and Coagulation, authored several book chapters and articles on topics in Hematology, and served on the ASCP’s Tech Sample Committee, Education Program Committee, and most recently, the Hematology Examination Committee.
Reviewer Information:
Joshua J. Cannon, MS, MLS(ASCP)CMSHCM received his Bachelor of Science and Master of Science in Medical Laboratory Science from Thomas Jefferson University in Philadelphia, PA. He holds Medical Laboratory Scientist and Specialist in Hematology certifications through the ASCP Board of Certification. He was a professor at Thomas Jefferson University for seven years before transitioning into his current role as Education Developer at MediaLab. His areas of expertise and professional passions include clinical hematology and interprofessional education.
Barbara Caldwell, MS, MLS(ASCP)SH is the administrative director of clinical laboratory services at Montgomery General Hospital in Olney, Maryland. She is also an experienced educator, having served as a Clinical Assistant Professor at the University of Maryland School of Medicine in the Department Of Medical and Research Technology. Ms. Caldwell holds an MS degree from the University of Maryland School of Medicine. She has authored numerous textbook chapters, articles, and abstracts related to topics in Hematology.
